RESUMEN
The molecular and cellular bases of motor neuron diseases (MNDs) are still poorly understood. The diseases are mostly sporadic, with ~10% of cases being familial. In most cases of familial motor neuronopathy, the disease is caused by either gain-of-adverse-effect mutations or partial loss-of-function mutations in ubiquitously expressed genes that serve essential cellular functions. Here we show that deletion of Scyl1, an evolutionarily conserved and ubiquitously expressed gene encoding the COPI-associated protein pseudokinase SCYL1, causes an early onset progressive MND with characteristic features of amyotrophic lateral sclerosis (ALS). Skeletal muscles of Scyl1(-/-) mice displayed neurogenic atrophy, fiber type switching, and disuse atrophy. Peripheral nerves showed axonal degeneration. Loss of lower motor neurons (LMNs) and large-caliber axons was conspicuous in Scyl1(-/-) animals. Signs of neuroinflammation were seen throughout the CNS, most notably in the ventral horn of the spinal cord. Neural-specific, but not skeletal muscle-specific, deletion of Scyl1 was sufficient to cause motor dysfunction, indicating that SCYL1 acts in a neural cell-autonomous manner to prevent LMN degeneration and motor functions. Remarkably, deletion of Scyl1 resulted in the mislocalization and accumulation of TDP-43 (TAR DNA-binding protein of 43 kDa) and ubiquilin 2 into cytoplasmic inclusions within LMNs, features characteristic of most familial and sporadic forms of ALS. Together, our results identify SCYL1 as a key regulator of motor neuron survival, and Scyl1(-/-) mice share pathological features with many human neurodegenerative conditions.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Enfermedad de la Neurona Motora/genética , Enfermedad de la Neurona Motora/metabolismo , Proteínas Quinasas/genética , Proteínas Adaptadoras Transductoras de Señales , Proteínas Adaptadoras del Transporte Vesicular/genética , Proteínas Adaptadoras del Transporte Vesicular/metabolismo , Secuencia de Aminoácidos , Esclerosis Amiotrófica Lateral/genética , Esclerosis Amiotrófica Lateral/patología , Animales , Proteínas Relacionadas con la Autofagia , Western Blotting , Células Clonales/fisiología , ADN/genética , Fuerza de la Mano/fisiología , Inmunohistoquímica , Cuerpos de Inclusión/metabolismo , Cuerpos de Inclusión/ultraestructura , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Electrónica de Transmisión , Mitocondrias/ultraestructura , Datos de Secuencia Molecular , Enfermedad de la Neurona Motora/patología , Neuronas Motoras/fisiología , Neuronas Motoras/ultraestructura , Músculo Esquelético/patología , Reacción en Cadena de la PolimerasaRESUMEN
Naive T cells encountering their cognate antigen become activated and acquire the ability to proliferate in response to cytokines. Stat5 is an essential component in this response. We demonstrate that Stat5 cannot access DNA in naive T cells and acquires this ability only after T-cell receptor (TCR) engagement. The transition is not associated with changes in DNA methylation or global histone modification but rather chromatin decondensation. Condensation occurs during thymocyte development and proper condensation is dependent on kleisin-ß of the condensin II complex. Our findings suggest that this unique chromatin condensation, which can affect interpretations of chromatin accessibility assays, is required for proper T-cell development and maintenance of the quiescent state. This mechanism ensures that cytokine driven proliferation can only occur in the context of TCR stimulation.
Asunto(s)
Adenosina Trifosfatasas/metabolismo , Ensamble y Desensamble de Cromatina/inmunología , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica/inmunología , Inmunidad Celular/inmunología , Activación de Linfocitos/inmunología , Complejos Multiproteicos/metabolismo , Factor de Transcripción STAT5/inmunología , Animales , Secuencia de Bases , Western Blotting , Proliferación Celular , Ensamble y Desensamble de Cromatina/fisiología , Inmunoprecipitación de Cromatina , Técnica del Anticuerpo Fluorescente , Interleucina-2/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Electrónica de Transmisión , Datos de Secuencia Molecular , Regiones Promotoras Genéticas/genética , Receptores de Antígenos de Linfocitos T/metabolismo , Factor de Transcripción STAT5/genética , Análisis de Secuencia de ADN , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/inmunologíaRESUMEN
Here we identify a component of the nuclear RNA cap-binding complex (CBC), Ars2, that is important for miRNA biogenesis and critical for cell proliferation. Unlike other components of the CBC, Ars2 expression is linked to the proliferative state of the cell. Deletion of Ars2 is developmentally lethal, and deletion in adult mice led to bone marrow failure whereas parenchymal organs composed of nonproliferating cells were unaffected. Depletion of Ars2 or CBP80 from proliferating cells impaired miRNA-mediated repression and led to alterations in primary miRNA processing in the nucleus. Ars2 depletion also reduced the levels of several miRNAs, including miR-21, let-7, and miR-155, that are implicated in cellular transformation. These findings provide evidence for a role for Ars2 in RNA interference regulation during cell proliferation.
Asunto(s)
Proliferación Celular , Complejo Proteico Nuclear de Unión a la Caperuza/metabolismo , Proteínas Nucleares/metabolismo , Interferencia de ARN , Animales , Arsénico/toxicidad , Línea Celular , Guanosina/análogos & derivados , Guanosina/metabolismo , Humanos , Ratones , MicroARNsRESUMEN
Janus kinase 2 (Jak2) has a pivotal role in erythropoietin (Epo) signaling pathway, including erythrocyte differentiation and Stat5 activation. In the course of screening for critical phosphorylation of tyrosine residues in Jak2, we identified tyrosine 913 (Y(913)) as a novel and functional phosphorylation site, which negatively regulates Jak2. Phosphorylation at Y(913) rapidly occurred and was sustained for at least 120 min after Epo stimulation, in contrast to the transient phosphorylation of Y(1007/1008) in the activation loop of Jak2. Interestingly, phosphorylation defective mutation of Y(913) (Y(913)F) results in a significant enhancement of Epo-induced Jak2 activation, whereas phosphorylation mimic mutation of Y(913) (Y(913)E) completely abrogated its activation. Furthermore, Jak2 deficient fetal liver cells expressing Y(913)F mutant generated many mature erythroid BFU-E and CFU-E colonies, while Y(913)E mutant failed to reconstitute Jak2 deficiency. We also demonstrate, in Jak1, phosphorylation of Y(939), a corresponding tyrosine residue with Y(913), negatively regulated Jak1 signaling pathway. Accordingly, our results suggest that this tyrosine phosphorylation in JH1 domain may be involved in common negative regulation mechanism for Jak family.
Asunto(s)
Eritropoyetina/metabolismo , Janus Quinasa 2/metabolismo , Fosfotirosina/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Ensayo de Unidades Formadoras de Colonias , Secuencia Conservada , Activación Enzimática/efectos de los fármacos , Células Eritroides/citología , Células Eritroides/efectos de los fármacos , Eritropoyetina/farmacología , Interferón gamma/farmacología , Janus Quinasa 2/química , Ratones , Mutación/genética , Fosforilación/efectos de los fármacosRESUMEN
Suppressor of cytokine signaling 3 (SOCS3) inhibits leukemia-inhibitory factor (LIF) signaling and acts as a negative regulator. Deletion of SOCS3 causes embryonic lethality because of placental failure, and genetic reduction of LIF or the LIF receptor (LIFR) in SOCS3-deficient mice rescues placental defects and embryonic lethality; this indicates that SOCS3 is an essential inhibitor of LIFR signaling. However, the downstream signaling molecule that acts as a link between the LIFR and SOCS3 has not been identified. In this study we explored the downstream signaling of LIFR. The administration of LIF to SOCS3-heterozygous pregnant mice promotes trophoblast giant cell differentiation and accelerates placental failure in SOCS3-deficient mice. SOCS3-deficient trophoblast stem cells show enhanced and prolonged signal transducer and activator of transcription 3 (Stat3) activation by LIF stimulation. Further, in the trophoblasts of SOCS3-deficient placenta and differentiating cells from the choriocarcinoma-derived cell line Rcho-1 cells, constitutive activation of Stat3 is observed. The forced expression of SOCS3, dominant-negative Stat3, and dominant-negative Janus kinase 1 (JAK1) in Rcho-1 cells significantly suppressed the trophoblast giant cell differentiation of these cells. In addition, the number of trophoblast giant cells is significantly reduced concomitant with an increased number of precursor trophoblasts in JAK1-deficient placentas. Finally, JAK1 deficiency rescues placental defects and embryonic lethality in SOCS3-deficient mice. These results indicate that the LIFR signaling is finely coordinated by JAK1, Stat3, and SOCS3 and regulates trophoblast giant cell differentiation. In addition, these data establish that LIFR-JAK1-Stat3-SOCS3 signaling is an essential pathway for the regulation of trophoblast giant cell differentiation.
Asunto(s)
Células Gigantes/citología , Janus Quinasa 1/metabolismo , Factor Inhibidor de Leucemia/metabolismo , Factor de Transcripción STAT3/metabolismo , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Trofoblastos/citología , Animales , Diferenciación Celular , Cruzamientos Genéticos , Genes Dominantes , Heterocigoto , Ratones , Microscopía Fluorescente , Ratas , Transducción de Señal , Proteína 3 Supresora de la Señalización de Citocinas , Trofoblastos/metabolismoRESUMEN
Cytokines affect a variety of cellular functions, including regulation of cell numbers by suppression of programmed cell death. Suppression of apoptosis requires receptor signalling through the activation of Janus kinases and the subsequent regulation of members of the B-cell lymphoma 2 (Bcl-2) family. Here we demonstrate that a Bcl-2-family-related protein, Hax1, is required to suppress apoptosis in lymphocytes and neurons. Suppression requires the interaction of Hax1 with the mitochondrial proteases Parl (presenilin-associated, rhomboid-like) and HtrA2 (high-temperature-regulated A2, also known as Omi). These interactions allow Hax1 to present HtrA2 to Parl, and thereby facilitates the processing of HtrA2 to the active protease localized in the mitochondrial intermembrane space. In mouse lymphocytes, the presence of processed HtrA2 prevents the accumulation of mitochondrial-outer-membrane-associated activated Bax, an event that initiates apoptosis. Together, the results identify a previously unknown sequence of interactions involving a Bcl-2-family-related protein and mitochondrial proteases in the ability to resist the induction of apoptosis when cytokines are limiting.
Asunto(s)
Metaloproteasas/metabolismo , Proteínas Mitocondriales/metabolismo , Procesamiento Proteico-Postraduccional , Proteínas/metabolismo , Serina Endopeptidasas/metabolismo , Animales , Apoptosis , Supervivencia Celular , Genes Letales , Serina Peptidasa A2 que Requiere Temperaturas Altas , Péptidos y Proteínas de Señalización Intracelular , Linfocitos/citología , Linfocitos/metabolismo , Metaloproteasas/deficiencia , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas Mitocondriales/química , Proteínas Mitocondriales/deficiencia , Neuronas/citología , Neuronas/metabolismo , Unión Proteica , Proteínas/genética , Serina Endopeptidasas/química , Proteína X Asociada a bcl-2/metabolismoRESUMEN
Janus kinases are essential for signal transduction by a variety of cytokine receptors and when inappropriately activated can cause hematopoietic disorders and oncogenesis. Consequently, it can be predicted that the interaction of the kinases with receptors and the events required for activation are highly controlled. In a screen to identify phosphorylation events regulating Jak2 activity in EpoR signaling, we identified a mutant (Jak2-Y613E) which has the property of being constitutively activated, as well as an inactivating mutation (Y766E). Although no evidence was obtained to indicate that either site is phosphorylated in signaling, the consequences of the Y613E mutation are similar to those observed with recently described activating mutations in Jak2 (Jak2-V617F and Jak2-L611S). However, unlike the V617F or L611S mutant, the Y613E mutant requires the presence of the receptor but not Epo stimulation for activation and downstream signaling. The properties of the Jak2-Y613E mutant suggest that under normal conditions, Jak2 that is not associated with a receptor is locked into an inactive state and receptor binding through the FERM domain relieves steric constraints, allowing the potential to be activated with receptor engagement.
Asunto(s)
Janus Quinasa 2/metabolismo , Receptores de Eritropoyetina/fisiología , Sustitución de Aminoácidos , Animales , Línea Celular , Células Cultivadas , ADN Complementario , Embrión de Mamíferos , Activación Enzimática , Femenino , Fibroblastos/metabolismo , Humanos , Janus Quinasa 2/química , Janus Quinasa 2/genética , Riñón/citología , Modelos Biológicos , Fenilalanina/metabolismo , Fosforilación , Plásmidos , Embarazo , Estructura Terciaria de Proteína , Receptores de Eritropoyetina/genética , Receptores de Eritropoyetina/metabolismo , Retroviridae/genética , TransfecciónRESUMEN
Gene array analysis has been widely used to identify genes induced during T cell activation. Our studies identified an immediate early gene that is strongly induced in response to IL-2 in mouse T cells which we named cysteine- serine-rich nuclear protein-1 (CSRNP-1). The human ortholog was previously identified as an AXIN1 induced gene (AXUD1). The protein does not contain sequence defined domains or motifs annotated in public databases, however the gene is a member of a family of three mammalian genes that share conserved regions, including cysteine- and serine-rich regions and a basic domain, they encode nuclear proteins, possess transcriptional activation domain and bind the sequence AGAGTG. Consequently we propose the nomenclature of CSRNP-1, -2 and -3 for the family. To elucidate the physiological functions of CSRNP-1, -2 and -3, we generated mice deficient for each of these genes by homologous recombination in embryonic stem cells. Although the CSRNP proteins have the hallmark of transcription factors and CSRNP-1 expression is highly induced by IL-2, deletion of the individual genes had no obvious consequences on normal mouse development, hematopoiesis or T cell functions. However, combined deficiencies cause partial neonatal lethality suggesting that the genes have redundant functions.
Asunto(s)
Cisteína/análisis , Proteínas Nucleares/química , Serina/análisis , Secuencia de Aminoácidos , Animales , Células Cultivadas , Humanos , Interleucina-2/genética , Interleucina-2/metabolismo , Ratones , Ratones Transgénicos , Proteínas Nucleares/metabolismo , Alineación de Secuencia , TransfecciónRESUMEN
Janus kinase 2 (Jak2) associates with cytokine receptors and is essential for signal transduction by mediating tyrosine phosphorylation. Kinase activity is regulated by a series of interactions beginning with the requirement to bind to specific domains in receptors, suppression of activation by the pseudokinase domain, and the requirement for phosphorylation within the activation loop. Recent studies have implicated de-regulation of Jak2 kinase activity by chromosomal translocations in hematopoietic tumors and mutations within the pseudokinase domain in a spectrum of myeloproliferative diseases.
Asunto(s)
Regulación Neoplásica de la Expresión Génica , Neoplasias Hematológicas/genética , Janus Quinasa 2/metabolismo , Modelos Moleculares , Trastornos Mieloproliferativos/genética , Transducción de Señal/fisiología , Translocación Genética/genética , Humanos , Mutación/genética , Fosforilación , Estructura Terciaria de Proteína , Receptores de Citocinas/metabolismo , Transducción de Señal/genética , Tirosina/metabolismoRESUMEN
The tyrosine kinase, Janus kinase-2 (Jak2), plays a pivotal role in signal transduction through a variety of cytokine receptors, including the receptor for erythropoietin (Epo). Although the physiological relevance of Jak2 has been definitively established, less is known about its regulation. In studies assessing the roles of sites of tyrosine phosphorylation, we identified Y(119) in the FERM (band 4.1, Ezrin, radixin and moesin) domain as a phosphorylation site. In these studies, we demonstrate that the phosphorylation of Y(119) in response to Epo downregulates Jak2 kinase activity. Using a phosphorylation mimic mutation (Y(119)E), downregulation is shown to involve dissociation of Jak2 from the receptor complex. Conversely, a Y(119)F mutant is more stably associated with the receptor complex. Thus, in cytokine responses, ligand binding induces activation of receptor associated Jak2, autophosphorylation of Y(119) in the FERM domain and the subsequent dissociation of the activated Jak2 from the receptor and degradation. This regulation occurs with the receptors for Epo, thrombopoietin and growth hormone but not with the receptor for interferon-gamma.
Asunto(s)
Janus Quinasa 2/metabolismo , Procesamiento Proteico-Postraduccional , Receptores de Citocinas/metabolismo , Transducción de Señal , Sustitución de Aminoácidos , Animales , Línea Celular , Citocinas/metabolismo , Humanos , Janus Quinasa 2/genética , Ligandos , Ratones , Ratones Transgénicos , Mutación Missense , Fosforilación , Unión Proteica/genética , Procesamiento Proteico-Postraduccional/genética , Estructura Terciaria de Proteína/genética , Receptores de Citocinas/agonistas , Transducción de Señal/genéticaRESUMEN
Biochemical and genetic studies have shown that Jak2 is an essential component of EpoR signal transduction which is required for normal erythropoiesis. However, whether Jak2 is the sole direct mediator of EpoR signal transduction remains controversial. To address this issue, we have used an extensive and systematic mutational analysis across the EpoR cytoplasmic tail and transmembrane domain with the goal of determining whether mutants that negatively affected EpoR biological activity but retained Jak2 activation could be identified. Analysis of over 40 mutant receptors established that two large domains in the membrane-proximal region, which include the previously defined Box1 and Box2 domains as well as a highly conserved glycine among cytokine receptors, are required for Jak2 binding and activation and to sustain biological activity of the receptor. Importantly, none of the mutants that lost the ability to activate Jak2 retained the ability to bind Jak2, thus questioning the validity of models of receptor reorientation for Jak2 activation. Also, no correlation was made between cell surface expression of the receptor and its ability to bind Jak2, thus questioning the role of Jak2 in trafficking the receptor to the plasma membrane. Collectively, the results suggest that Jak2 is the sole direct signaling molecule downstream of EpoR required for biological activity.
Asunto(s)
Janus Quinasa 2/metabolismo , Janus Quinasa 2/fisiología , Receptores de Eritropoyetina/genética , Receptores de Eritropoyetina/metabolismo , Transducción de Señal , Secuencia de Aminoácidos , Animales , Humanos , Janus Quinasa 2/genética , Ratones , Datos de Secuencia Molecular , Mutación , Células 3T3 NIH , Unión Proteica , Estructura Terciaria de Proteína , Transporte de Proteínas , Receptores de Eritropoyetina/fisiología , Homología de Secuencia de Aminoácido , TransfecciónRESUMEN
Activation of the transcription factors STAT5A and STAT5B by JAK1 and JAK3 tyrosine kinases is a key event in downstream signaling of gammac (common gamma chain)-family cytokine receptors in lymphoid cells. STAT5A/B-deficiency in mice causes, among other consequences, a reduced size and altered composition of the peripheral T-cell pool with predominance of an activated or memory-like population (CD4(+)/CD44(high)/CD62L(low)) and a proliferative deficiency following antigenic stimulation and subsequent IL-2 treatment. To further elucidate the critical function of STAT5A/B in homeostasis and activation of murine naïve peripheral T-lymphocytes, we have analyzed global gene expression of STAT5A/B-deficient versus wild-type splenic T-cells by profiling with high-density oligonucleotide arrays (Affymetrix). Comparison of (1) basal gene expression of untreated peripheral STAT5A/B-deficient and control T-cells and (2) immediate early gene induction upon in vitro stimulation of either population with IL-2 has revealed differential expression of a broad range of genes potentially contributing to the defects of STAT5A/B deficient T-cells. In the context of enhanced apoptotic rates of STAT5A/B(-/-)-T-cells in vivo and upon TCR-stimulation in culture our data suggest a role for STAT5 in post-activation survival beyond regulation of antiapoptotic Bcl-2 proteins and hence provide new insights into the nature of the late proliferative block in the T-cell compartment caused by STAT5-deficiency.
Asunto(s)
Apoptosis/inmunología , Perfilación de la Expresión Génica , Factor de Transcripción STAT5/metabolismo , Linfocitos T/metabolismo , Animales , Northern Blotting , Western Blotting , Análisis por Conglomerados , Activación Enzimática , Regulación de la Expresión Génica , Interleucina-2/metabolismo , Ratones , Ratones Noqueados , Factor de Transcripción STAT5/deficiencia , Factor de Transcripción STAT5/aislamiento & purificación , Bazo/citología , Bazo/metabolismo , Activación TranscripcionalRESUMEN
Stem cells have important clinical and experimental potentials. Trophoblast stem (TS) cells possess the ability to differentiate into trophoblast subtypes in vitro and contribute to the trophoblast lineage in vivo. Suppressor of cytokine signaling 3 (SOCS3) is a negative regulator of cytokine signaling. Targeted disruption of SOCS3 revealed embryonic lethality on E12.5; it was caused by placental defect with enhanced leukemia inhibitory factor receptor signaling. A complementation of the wild-type (WT) placenta by using tetraploid rescue technique showed that the embryonic lethality in SOCS3-deficient embryo was due to the placental defect. Here we demonstrate that TS cells supplementation rescues placental defect in SOCS3-deficient embryos. In the rescued placenta, TS cells were integrated into the placental structure, and a substantial structural improvement was observed in the labyrinthine layer that was disrupted in the SOCS3-deficient placenta. Importantly, by supplying TS cells, living SOCS3-deficient embryos were detected at term. These results indicate a functional contribution of TS cells in the placenta and their potential application.
Asunto(s)
Enfermedades Placentarias , Placenta/embriología , Trasplante de Células Madre , Proteínas Supresoras de la Señalización de Citocinas/fisiología , Trofoblastos/trasplante , Animales , Femenino , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Placenta/anomalías , Enfermedades Placentarias/patología , Enfermedades Placentarias/prevención & control , Embarazo , Proteína 3 Supresora de la Señalización de Citocinas , Proteínas Supresoras de la Señalización de Citocinas/genéticaRESUMEN
Friend virus is an acutely oncogenic retrovirus that causes erythroblastosis and polycythemia in mice. Previous studies suggested that the Friend virus oncoprotein, gp55, constitutively activates the erythropoietin receptor (EPOR), causing uncontrolled erythroid proliferation. Those studies showed that gp55 confers growth factor independence on an interleukin-3 (IL-3)-dependent cell line (Ba/F3) when the EPOR is coexpressed. Subsequently, we showed that a truncated form of the stem-cell kinase receptor (sf-STK) is required for susceptibility to Friend disease. Given the requirement for sf-STK, we sought to establish the in vivo significance of gp55-mediated activation of the EPOR. We found that the cytoplasmic tyrosine residues of the EPOR, and signal transducer and activator of transcription-5 (STAT5), which acts through these sites, are not required for Friend virus-induced erythroblastosis. The EPOR itself was required for the development of erythroblastosis but not for gp55-mediated erythroid proliferation. Interestingly, the murine EPOR, which is required for gp55-mediated Ba/F3-cell proliferation, was dispensable for erythroblastosis in vivo. Finally, gp55-mediated activation of the EPOR and STAT5 are required for Friend virus-induced polycythemia. These results suggest that Friend virus activates both sf-STK and the EPOR to cause deregulated erythroid proliferation and differentiation.
Asunto(s)
Virus de la Leucemia Murina de Friend/patogenicidad , Leucemia Experimental/virología , Policitemia/virología , Receptores de Eritropoyetina/fisiología , Proteínas del Envoltorio Viral/fisiología , Animales , Diferenciación Celular , Proliferación Celular , Transformación Celular Viral , Eritroblastos/patología , Eritroblastos/virología , Leucemia Experimental/etiología , Leucemia Experimental/patología , Ratones , Ratones Noqueados , Receptores de Eritropoyetina/metabolismo , Infecciones por Retroviridae , Factor de Transcripción STAT5/metabolismo , Factor de Transcripción STAT5/fisiología , Transducción de Señal/fisiología , Infecciones Tumorales por VirusRESUMEN
The Evi-1 gene was first identified as a site for viral integration in murine myeloid leukemia. Evi-1 is a zinc finger transcription factor that has been implicated in the development of myeloid neoplasia. In humans, disruption of the Evi-1 locus, by chromosomal rearrangements, is associated with myeloid leukemia and myelodyplastic syndromes. Here, we report the cloning and developmental pattern of expression of Xenopus Evi-1. xEvi-1 is expressed during oogenesis and during embryonic development. In situ hydridization reveals that xEvi-1 has a dynamic expression profile during early embryonic development. Expression of Evi-1 is detected by in situ hybridization in the pronephric tissue, the brain and in neural crest derivatives of the head and neck.
Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Regulación del Desarrollo de la Expresión Génica , Factores de Transcripción/biosíntesis , Secuencia de Aminoácidos , Animales , Northern Blotting , Encéfalo/metabolismo , Clonación Molecular , ADN Complementario/metabolismo , Biblioteca de Genes , Hibridación in Situ , Riñón/embriología , Proteína del Locus del Complejo MDS1 y EV11 , Ratones , Datos de Secuencia Molecular , Cresta Neural/metabolismo , Oocitos/metabolismo , Poli A/química , Proto-Oncogenes , Homología de Secuencia de Aminoácido , Factores de Tiempo , Transcripción Genética , Xenopus laevisRESUMEN
Activation of Stat5 is frequently found in leukemias. To study the mechanism and role of Stat5 activation, we introduced a constitutively activated Stat5a mutant, cS5F, into murine bone marrow (BM) cells. BM transplantation with cS5F-transfected cells caused development of multilineage leukemias in lethally irradiated wild-type or nonirradiated Rag2(-/-) mice. The leukemic cells showed strongly enhanced levels of cS5F tetramers but unchanged cS5F dimer levels in a DNA binding assay. Moreover, Stat5a mutants engineered to form only dimers, but not tetramers, failed to induce leukemias. In addition, Stat5 tetramers were found to accumulate in excess compared to dimers in various human leukemias. These data suggest that Stat5 tetramers are associated with leukemogenesis.
Asunto(s)
Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/metabolismo , Leucemia/metabolismo , Proteínas de la Leche/química , Proteínas de la Leche/metabolismo , Estructura Cuaternaria de Proteína , Transactivadores/química , Transactivadores/metabolismo , Animales , Biomarcadores , Células de la Médula Ósea/citología , Células de la Médula Ósea/fisiología , Trasplante de Médula Ósea , Linaje de la Célula , Transformación Celular Neoplásica , Células Cultivadas , Proteínas de Unión al ADN/genética , Femenino , Prueba de Complementación Genética , Sustancias de Crecimiento/metabolismo , Humanos , Leucemia/genética , Leucemia/patología , Hígado/metabolismo , Hígado/patología , Masculino , Ratones , Ratones Noqueados , Proteínas de la Leche/genética , Mutación , Proteínas Nucleares , Oncogenes , Factor de Transcripción STAT5 , Bazo/metabolismo , Bazo/patología , Transactivadores/genética , Transfección , Proteínas Supresoras de TumorRESUMEN
The two highly related signal transducers and activators of transcription (Stats), Stat5a and Stat5b, are major mediators of prolactin signaling in both the mammary gland and in the ovary. Deficiencies in Stat5b, or in both Stat5a and Stat5b, result in loss of pregnancy during midgestation and are correlated with an increase in ovarian 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD) and a decrease in serum progesterone, which normally declines only immediately before parturition. To determine the relative contribution of 20alpha-HSD to progesterone metabolism and Stat5 function during pregnancy and parturition, we created a 20alpha-HSD-deficient strain of mice by gene disruption. Mice deficient for 20alpha-HSD sustain high progesterone levels and display a delay in parturition of several days demonstrating that 20alpha-HSD regulates parturition downstream of the prostaglandin F2alpha receptor in an essential and nonredundant manner. Moreover, 20alpha-HSD deficiency partially corrected the abortion of pregnancies associated with Stat5b deficiency, supporting the concept that prolactin activation of Stat5b is important in suppressing 20alpha-HSD gene expression and thereby allowing the maintenance of progesterone levels that are required to sustain pregnancy.
Asunto(s)
20-alfa-Hidroxiesteroide Deshidrogenasa/metabolismo , Proteínas de Unión al ADN/metabolismo , Proteínas de la Leche/metabolismo , Preñez , Progesterona/biosíntesis , Transactivadores/metabolismo , Glándulas Suprarrenales/metabolismo , Animales , Northern Blotting , Western Blotting , Cloprostenol/farmacología , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Electroforesis en Gel de Poliacrilamida , Femenino , Vectores Genéticos , Genotipo , Hematopoyesis , Células Madre Hematopoyéticas/citología , Riñón/metabolismo , Glándulas Mamarias Animales/metabolismo , Ratones , Mifepristona/farmacología , Modelos Genéticos , Mutación , Ovario/metabolismo , Parto , Embarazo , Progesterona/sangre , Progesterona/metabolismo , Radioinmunoensayo , Receptores de Prostaglandina/metabolismo , Factor de Transcripción STAT5 , Factores de TiempoRESUMEN
Janus kinases are the key enzymes involved in the initial transmission of signals in response to type I and II cytokines. Activation of the signal begins with the transphosphorylation of Jak kinases. Substrates that give rise to downstream events are recruited to the receptor complex in part by interactions with phosphorylated tyrosines. The identity of many of the phosphotyrosines responsible for recruitment has been elucidated as being receptor-based tyrosines. The ability of Jaks to recruit substrates through their own phosphotyrosines has been demonstrated for tyrosines in the kinase activation loop. Recent studies demonstrate that other tyrosines have implications in regulatory roles of Jak kinase activity. In this study, baculovirus-produced Jak2 was utilized to demonstrate that transphosphorylation of Jak kinases occurs on multiple residues throughout the protein. We demonstrate that among the tyrosines phosphorylated, those in the kinase domain occur as expected, but many other sites are also phosphorylated. The tyrosines conserved in the Jak family are the object of this study, although many of them are phosphorylated, many are not. This result suggests that conservation of tyrosines is perhaps as important in maintaining structure of the Jak family. Additionally, non-Jak family conserved tyrosines are phosphorylated suggesting that the individual Jaks ability to phosphorylated specific tyrosines may influence signals emitting from activated Jaks.
Asunto(s)
Proteínas Tirosina Quinasas/química , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas/química , Proteínas Proto-Oncogénicas/metabolismo , Secuencia de Aminoácidos , Animales , Sitios de Unión , Línea Celular , Cromatografía Líquida de Alta Presión , Cromatografía en Capa Delgada/métodos , Eliminación de Gen , Inmunoprecipitación , Janus Quinasa 2 , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Fosfopéptidos/química , Fosfopéptidos/genética , Fosfopéptidos/metabolismo , Fosforilación , Estructura Terciaria de Proteína , Proteínas Tirosina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Spodoptera/citología , Tripsina/metabolismo , Tirosina/genética , Tirosina/metabolismoRESUMEN
Suppressor of cytokine signaling 1 (SOCS1) is an obligate negative regulator of cytokine signaling and most importantly in vivo, signaling via the interferon-gamma (IFN-gamma) receptor. SOCS1, via its Src homology 2 domain, binds to phosphotyrosine residues in its targets, reducing the amplitude of signaling from cytokine receptors. SOCS1 is also implicated in blocking Toll-like receptor (TLR) signaling in macrophages activated by TLR agonists such as lipopolysaccharide (LPS), thus regulating multiple steps in the activation of innate immune responses. To rigorously test this, we isolated macrophages from Socs1-/- mice on multiple genetic backgrounds. We found no evidence that SOCS1 blocked TLR-activated pathways, endotoxin tolerance, or nitric oxide production. However, Socs1-/-;IFN-gamma-/- mice were extremely susceptible to LPS challenge, confirming previous findings. Because LPS induces IFN-beta production from macrophages, we tested whether SOCS1 regulates IFN-alpha/beta receptor signaling. We find that SOCS1 is required to inhibit IFN-alpha/beta receptor signaling in vitro. Furthermore, the absence of a single allele encoding TYK2, a JAK (Janus kinase) family member essential IFN-alpha/beta receptor signaling, rescued Socs1-/- mice from early lethality, even in the presence of IFN-gamma. We conclude that previous reports linking SOCS1 to TLR signaling are most likely due to effects on IFN-alpha/beta receptor signaling.
Asunto(s)
Proteínas Portadoras/fisiología , Glicoproteínas de Membrana/fisiología , Receptores de Superficie Celular/fisiología , Proteínas Represoras/fisiología , Transducción de Señal/fisiología , Animales , Proteínas Portadoras/genética , Proteínas de Unión al ADN/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Proteínas I-kappa B/metabolismo , Interferón gamma/deficiencia , Interferón gamma/genética , Interferón gamma/fisiología , Lipopolisacáridos/farmacología , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Macrófagos/fisiología , Glicoproteínas de Membrana/agonistas , Proteínas de la Membrana , Ratones , Ratones Noqueados , Inhibidor NF-kappaB alfa , Fosforilación , Proteínas Tirosina Quinasas/deficiencia , Proteínas Tirosina Quinasas/genética , Proteínas Tirosina Quinasas/fisiología , Receptor de Interferón alfa y beta , Receptores de Superficie Celular/agonistas , Receptores de Interferón/antagonistas & inhibidores , Receptores de Interferón/fisiología , Proteínas Represoras/genética , Factor de Transcripción STAT1 , Proteína 1 Supresora de la Señalización de Citocinas , Proteínas Supresoras de la Señalización de Citocinas , TYK2 Quinasa , Receptores Toll-Like , Transactivadores/metabolismoRESUMEN
TACC2 is a member of the transforming acidic coiled-coil-containing protein family and is associated with the centrosome-spindle apparatus during cell cycling. In vivo, the TACC2 gene is expressed in various splice forms predominantly in postmitotic tissues, including heart, muscle, kidney, and brain. Studies of human breast cancer samples and cell lines suggest a putative role of TACC2 as a tumor suppressor protein. To analyze the physiological role of TACC2, we generated mice lacking TACC2. TACC2-deficient mice are viable, develop normally, are fertile, and lack phenotypic changes compared to wild-type mice. Furthermore, TACC2 deficiency does not lead to an increased incidence of tumor development. Finally, in TACC2-deficient embryonic fibroblasts, proliferation and cell cycle progression as well as centrosome numbers are comparable to those in wild-type cells. Therefore, TACC2 is not required, nonredundantly, for mouse development and normal cell proliferation and is not a tumor suppressor protein.